In patients with mild–moderate HF, spironolactone decreased neurohumoral activation (as reflected by BNP levels) and an indicator of collagen turnover (PIIINP) but worsened renal function and quality of life [66]. This evidence concerns the gene NPPB and hydrops fetalis.